Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Lugli

Showing results (51-60 of 184) with videos related to

Pageof 19
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 7, 2012
Intra-tumoral budding in preoperative biopsy specimens predicts lymph node and distant metastasis in patients with colorectal cancerOlivier T Giger, Sarah C M Comtesse, Alessandro Lugli, et al.
Journal of Translational Medicine|August 28, 2015
Loss of tapasin correlates with diminished CD8(+) T-cell immunity and prognosis in colorectal cancerLena Sokol, Viktor H Koelzer, Tilman T Rau, et al.
Histopathology|March 2, 2018
Tumour budding in pancreatic cancer revisited: validation of the ITBCC scoring systemEva Karamitopoulou, Martin Wartenberg, Inti Zlobec, et al.
Histopathology|November 17, 2009
Systematic assessment of the prognostic impact of membranous CD44v6 protein expression in colorectal cancerInti Zlobec, Ursula Günthert, Luigi Tornillo, et al.
Human Pathology|January 28, 2004
Frequent EpCam protein expression in human carcinomasPhilip Th Went, Alessandro Lugli, Sandra Meier, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 3, 2006
Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancerInti Zlobec, Russell Steele, René P Michel, et al.
Cancer|December 14, 2007
Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancerInti Zlobec, Parham Minoo, Daniel Baumhoer, et al.
Human Pathology|November 20, 2012
Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancerMilo Horcic, Viktor H Koelzer, Eva Karamitopoulou, et al.
Journal of Pathology Informatics|January 11, 2020
A Digital Pathology-Based Shotgun-Proteomics Approach to Biomarker Discovery in Colorectal CancerStefan Zahnd, Sophie Braga-Lagache, Natasha Buchs, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 6, 2007
Prognostic significance of mammalian sterile20-like kinase 1 in colorectal cancerParham Minoo, Inti Zlobec, Kristi Baker, et al.
Pageof 19

Showing results (51-60 of 184) with videos related to

Sort By:
Pageof 19
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 7, 2012
Intra-tumoral budding in preoperative biopsy specimens predicts lymph node and distant metastasis in patients with colorectal cancerOlivier T Giger, Sarah C M Comtesse, Alessandro Lugli, et al.
Journal of Translational Medicine|August 28, 2015
Loss of tapasin correlates with diminished CD8(+) T-cell immunity and prognosis in colorectal cancerLena Sokol, Viktor H Koelzer, Tilman T Rau, et al.
Histopathology|March 2, 2018
Tumour budding in pancreatic cancer revisited: validation of the ITBCC scoring systemEva Karamitopoulou, Martin Wartenberg, Inti Zlobec, et al.
Histopathology|November 17, 2009
Systematic assessment of the prognostic impact of membranous CD44v6 protein expression in colorectal cancerInti Zlobec, Ursula Günthert, Luigi Tornillo, et al.
Human Pathology|January 28, 2004
Frequent EpCam protein expression in human carcinomasPhilip Th Went, Alessandro Lugli, Sandra Meier, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 3, 2006
Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancerInti Zlobec, Russell Steele, René P Michel, et al.
Cancer|December 14, 2007
Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancerInti Zlobec, Parham Minoo, Daniel Baumhoer, et al.
Human Pathology|November 20, 2012
Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancerMilo Horcic, Viktor H Koelzer, Eva Karamitopoulou, et al.
Journal of Pathology Informatics|January 11, 2020
A Digital Pathology-Based Shotgun-Proteomics Approach to Biomarker Discovery in Colorectal CancerStefan Zahnd, Sophie Braga-Lagache, Natasha Buchs, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 6, 2007
Prognostic significance of mammalian sterile20-like kinase 1 in colorectal cancerParham Minoo, Inti Zlobec, Kristi Baker, et al.
Pageof 19